Cutler Group LP Veru Inc. Transaction History

Cutler Group LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 18, 2023	SELL	$0.98 - $1.49 $6,279 - $9,547	-6,408 Reduced 78.07%	1,800 $2,000
Q1 2023 May 01, 2023	SELL	$1.16 - $6.41 $3,248 - $17,948	-2,800 Reduced 25.44%	8,208 $9,000
Q4 2022 Feb 07, 2023	SELL	$4.78 - $15.01 $73,234 - $229,968	-15,321 Reduced 58.19%	11,008 $58,000
Q3 2022 Oct 25, 2022	BUY	$10.22 - $23.7 $30,547 - $70,839	2,989 Added 12.81%	26,329 $303,000
Q2 2022 Aug 04, 2022	BUY	$4.35 - $15.85 $74,746 - $272,350	17,183 Added 279.08%	23,340 $263,000
Q1 2022 Apr 14, 2022	SELL	$4.55 - $6.41 $20,074 - $28,280	-4,412 Reduced 41.74%	6,157 $29,000
Q4 2021 Jan 18, 2022	SELL	$5.89 - $9.73 $12,592 - $20,802	-2,138 Reduced 16.83%	10,569 $62,000
Q3 2021 Oct 26, 2021	BUY	$6.78 - $9.89 $83,068 - $121,172	12,252 Added 2692.75%	12,707 $108,000
Q2 2021 Jul 19, 2021	SELL	$7.24 - $11.2 $26,498 - $40,992	-3,660 Reduced 88.94%	455 $3,000
Q1 2021 Apr 26, 2021	BUY	$8.05 - $20.78 $24,270 - $62,651	3,015 Added 274.09%	4,115 $44,000
Q4 2020 Jan 21, 2021	BUY	$2.36 - $9.99 $2,596 - $10,989	1,100 New	1,100 $9,000

122

56.8M

668K

531K

Ticker VERU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,146,704
Market Cap $46.5M
Description
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.